Ace Therapeutics is a preclinical R&D outsourcing service provider offering comprehensive preclinical depression research and antidepressant drug development services to clients worldwide. Our expertise and advanced technology in the field of psychiatric disorders allow us to provide comprehensive solutions covering the entire process, from drug screening to mechanism of action studies. Our high-quality research and testing services will provide you with reliable data to accelerate your innovation in the diagnosis and treatment of depression.

What We Offer in Preclinical R&D for Depression

Ace Therapeutics has extensive experience in psychopathology research and antipsychotic drug development. We are committed to supporting scientists in making breakthrough scientific discoveries and developing new applications to accelerate drug discovery and the scientific diagnosis and treatment of antipsychotics. We offer many research services including but not limited to:

Research Service on Mechanisms Related to Depression

We assist our clients in investigating the underlying pathological mechanisms of depression through the use of advanced techniques in molecular biology, histology, electrophysiology, and neuroimaging. Our research services encompass a range of molecular aspects related to depression, including heritability, neurotransmitter systems, the hypothalamic-pituitary-adrenal axis, neurotrophic factors and neurogenesis, neuroinflammation, metabolic disorders, the microbial-gut-brain axis, oxidative-antioxidant imbalance, mitochondrial dysfunction, and circadian rhythm-related gene dysregulation. Our comprehensive services are designed to assist clients in identifying and discovering new targets, thereby providing scientific support for the precise diagnosis of depression and the development of innovative therapies.

Preclinical Screening and Testing Services for Antidepressants

Ace Therapeutics has extensive experience in psychopathology research and antipsychotic drug development. We are committed to supporting scientists in making groundbreaking scientific discoveries and developing new applications to accelerate drug discovery and the scientific diagnosis and treatment of antipsychotic disorders. We offer many research services including but not limited to:

• Drug mechanism of action studies: We can assist you in studying the mechanism of action of antidepressants to better understand how these drugs work at the chemical and neurobiological levels.
• Drug safety and efficacy studies: We can help you evaluate the safety and efficacy of antidepressants and explore ways to optimize the therapeutic effects of these drugs.
• Development of new antidepressants: We help you develop new antidepressants that may be helpful for patients who do not adapt to existing medications or for those who have lost the effectiveness of their medications.
• Research on personalized treatment with antidepressants: Because of differences in the symptoms and presentation of depression, personalized treatment has become a hot topic of research in recent years. We can help you explore how to develop the best treatment options based on a patient's specific symptoms and presentation.
• Depression Diagnostic Method Development Services

• Biomarker-based Diagnostic Method Development Services
• Brain imaging diagnostic method development services

Related Services

• Depression animal models
• Depression behavior tests
• Histological analysis in psychiatry
• Cellular model development for depression

Ace Therapeutics, a preclinical R&D outsourcing service provider, is committed to providing a full range of preclinical research services to global pharmaceutical companies, research institutions, and investigators to advance the process of antipsychotic drug research. If you are interested in our services, please feel free to contact us.